FindMyRecallSubscribe
Class I: serious health riskOngoing

Liebel-Flarsheim Optiray Imaging Bulk Package-350 Recall

Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound I…

Liebel-Flarsheim Company LLC · Raleigh, NC

Risk level
Class I
Reported by FDA
Aug 19, 2026
Recall ID
D-0773-2026
Check your lot numberHow we source this data

Summary

Liebel-Flarsheim recalled Optiray Imaging Bulk Package-350 starting Jul 31, 2026. The FDA classified it as Class I (serious health risk) and published enforcement report D-0773-2026 on Aug 19, 2026. Reason: Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

Product description

Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution, Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616, Made in USA, NDC 0019-1333-65.

Lot numbers, UPCs & expiration codes

Lot # 25ZF3670, Exp Date: May 31, 2027.

Where it was sold

Distributed Nationwide in the US and Mexico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0773-2026
Classification
Class I
Status
Ongoing
Recall initiated
Jul 31, 2026
FDA report date
Aug 19, 2026
Quantity
3,486 500mL-vials
Recall type
Voluntary: Firm initiated
Recalling firm
Liebel-Flarsheim Company LLC

Original FDA data

Every field from FDA enforcement report D-0773-2026, exactly as published.

Show all FDA fields
City
Raleigh
State
NC
Status
Ongoing
Country
United States
Event ID
99510
Address
8800 Durant Rd
Code information
Lot # 25ZF3670, Exp Date: May 31, 2027.
Postal code
27616-3104
Report date
Aug 19, 2026
Product type
Drugs
Recall number
D-0773-2026
Classification
Class I
Recalling firm
Liebel-Flarsheim Company LLC
Product quantity
3,486 500mL-vials
Reason for recall
Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution, Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616, Made in USA, NDC 0019-1333-65.
Distribution pattern
Distributed Nationwide in the US and Mexico.
Recall initiation date
Jul 31, 2026
Initial firm notification
E-Mail
Center classification date
Aug 19, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0773-2026, published Aug 19, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls